Pharmafile Logo
Pharmafocus logo
Advanced Search

HIV

Showing 14 posts of 194 posts found.

New market access approach could save poorer countries millions

December 1, 2009
Sales and Marketing HIV, access, developing world

  An innovative approach to improving access to drugs for HIV/Aids, tuberculosis and malaria could save poorer countries millions of …

News

GlaxoSmithKline-Pfizer launch HIV joint venture

November 4, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer, ViiV

GlaxoSmithKline and Pfizer have launched a specialist HIV company with access to ten medicines developed by the two manufacturers.ViiV Healthcare, …

News

Pfizer agrees price cut in Clinton deal

September 1, 2009
Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

News

Pfizer agrees price cut in Clinton deal

August 7, 2009
Research and Development, Sales and Marketing HIV, Pfizer, generics

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

News

GSK and Pfizer to create HIV joint venture company

April 16, 2009
Research and Development, Sales and Marketing GSK, HIV, Pfizer

The world's two biggest pharma companies are to join forces to develop and market new treatments for HIV.GlaxoSmithKline is a …

News

GSK: renewing the HIV pipeline

February 16, 2009
Research and Development GSK, HIV

GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …

News

Latest news from Datamonitor

October 13, 2008
Sales and Marketing HIV

Battle for HIV drug market share getting fiercerThe HIV market, worth $9.3 billion in 2007, is expected to grow to …

News

Atripla approved in Europe

January 3, 2008
Sales and Marketing HIV

The first ever product to combine all the drugs HIV patients need in just one daily pill has been approved …

News

Pfizer’s Celsentri approved in Europe

September 25, 2007
Research and Development, Sales and Marketing HIV

Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …

News

FDA approves Pfizer’s first-in-class HIV drug

August 8, 2007
Sales and Marketing HIV

Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …

News

Gates Foundation could rival pharma, analysts warn

May 15, 2007
Sales and Marketing Gates Foundation, HIV, TB, vaccines

 The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …

News

Abbott lowers prices on HIV drugs

April 12, 2007
Sales and Marketing HIV, par

Intervention from the World Health Organisation has spurred Abbott to lower its prices on HIV drugs in developing countries.The company …

News

HIV market: collaborative combinations

March 26, 2007
Research and Development, Sales and Marketing HIV, drug development, marketing

Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …

Feature

Abbott withdraws HIV drugs from Thailand after patent row

March 21, 2007
Sales and Marketing HIV

Abbott Laboratories' tit-for-tat decision to withold new HIV treatments from Thailand has drawn an angry response from the Aids Healthcare …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023